PharmTech is rebranding to strengthen its commitment to scientists, innovators, and executives in the pharmaceutical industry ...
The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.
Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...
Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. and navigating the impact of the Inflation Reduction Act (IRA), the company has penned an acquisition of fellow ...
Suzhou Zion Pharma Technology Co Ltd. has identified KRAS inhibitors, in particular GTPase KRAS G12D mutant and/or G13D mutant, reported to be useful for the treatment of cancer. Suzhou Zion Pharma ...
New global study of 250 pharma leaders shows rapid uptake of agentic AI; early adopters focus on market intelligence, patient support, compliance and data integration. As the industry seeks to grasp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results